Bio-Rad Laboratories, Inc. (BIO) vs DaVita Inc. (DVA)
DVA leads on 11 of 14 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and DaVita Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIO vs DVA
growth of $100 · last 30yBIO +1488.6%DVA +2592.4%DVA compounded faster
BIO DVA
BIO vs DVA: by the numbers
- •DVA is the larger company ($13.40B vs $7.73B market cap).
- •DVA trades at the lower earnings multiple (20.99 vs 47.11 P/E).
- •BIO converts more revenue to profit (6.52% vs 5.65% net margin).
- •DVA grew revenue faster over the past five years (3.71% vs -0.84% CAGR).
Which is better, BIO or DVA?
Metric tally: BIO 3 · DVA 11It depends on what you're optimizing for:
ValueDVA(lower P/E)
GrowthDVA(faster 5Y revenue CAGR)
QualityDVA(higher ROIC)
Metrics side by side
Valuation
| Metric | BIO | DVA |
|---|---|---|
| P/E ratio | 47.11 | 20.99● |
| Forward P/E | 28.69 | 14.05● |
| P/S ratio | 2.98 | 1.04● |
| P/B ratio | 1.13 | — |
| PEG ratio | — | 2.54 |
| EV / EBITDA | 18.27 | 9.95● |
| FCF yield | 4.63% | 10.38%● |
Profitability
| Metric | BIO | DVA |
|---|---|---|
| Gross margin | 51.87%● | 31.10% |
| Operating margin | 9.25% | 15.01%● |
| Net margin | 6.52%● | 5.65% |
| ROE | 2.46%● | -114.70% |
| ROIC | 2.04% | 10.58%● |
Growth (annualized)
| Metric | BIO | DVA |
|---|---|---|
| Revenue CAGR (5Y) | -0.84% | 3.71%● |
| EPS CAGR (5Y) | -26.27% | 8.25%● |
| FCF CAGR (5Y) | -7.57% | 6.13%● |
| Total return CAGR (5Y) | -13.82% | 11.28%● |
Frequently asked
- Which is better, BIO or DVA?
- It depends on your goal. value: DVA (lower P/E); growth: DVA (faster 5Y revenue CAGR); quality: DVA (higher ROIC). Across all compared metrics, DVA leads 11 to 3.
- Is BIO or DVA cheaper?
- On trailing earnings, DVA is cheaper: BIO trades at a 47.11 P/E and DVA at 20.99.
- Which has grown faster, BIO or DVA?
- Over the past five years, DVA grew revenue faster — BIO at a -0.84% CAGR versus DVA at 3.71%.
- Is BIO or DVA more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus DVA at 5.65%.
- Which has been the better investment, BIO or DVA?
- Over the past 10-year, DVA delivered the higher annualized total return — BIO at 6.91% versus DVA at 10.61%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioDaVita P/E ratioBio-Rad Laboratories dividend yieldDaVita dividend yieldBio-Rad Laboratories ROEDaVita ROEBio-Rad Laboratories operating marginDaVita operating marginBio-Rad Laboratories revenue growthDaVita revenue growthBio-Rad Laboratories free cash flowDaVita free cash flow
Bio-Rad Laboratories & DaVita appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.